Financials
Financial year 2026
PHARMAKES from Ieper, company number BE0845691926, closed financial year 2026 with a result of € 91,541 after tax. For that financial year PHARMAKES recorded a gross margin of € 185,328 and equity of € 1.1 million. Compared with financial year 2025, the result moved from € 32,749 to € 91,541. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2026.
€ 1.1 million
▼ 9% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 91,541
▲ 180% vs 2025
Profit after tax over the fiscal year.
€ 64,956
▲ € 49,797 vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 203,080 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2026
0
Average over the fiscal year, from the social balance sheet.
€ 29,779
▼ 32% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 475,582
▼ 13% vs 2025
€ 72,246 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 1,676
▲ 25% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 9,792
▲ 44% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 477,209 | € 220,256 | € 95,565 | € 185,328 | ▲ 94% |
| Profit after taxes | € 283,001 | € 110,072 | € 32,749 | € 91,541 | ▲ 180% |
| Equity | € 1,047,432 | € 1,156,670 | € 1,189,419 | € 1,077,880 | ▼ 9% |
| Total debts | € 1,196,690 | € 882,091 | € 553,904 | € 490,712 | ▼ 11% |
| Cash | € 486,813 | € 239,171 | € 15,160 | € 64,956 | ▲ € 49,797 |
| Retained profit | € 1,028,832 | € 1,138,070 | € 1,170,819 | € 1,059,280 | ▼ 10% |
| Dividend | € 0 | € 834 | € 0 | € 203,080 | |
| Bank debt | € 716,071 | € 612,604 | € 544,490 | € 475,582 | ▼ 13% |
| Balance sheet total | € 2,244,122 | € 2,038,761 | € 1,743,323 | € 1,568,592 | ▼ 10% |
By gross margin, PHARMAKES ranks 5th of 11 companies with main activity “Detailhandel in farmaceutische producten” in Ieper that publish figures (fiscal year 2026).
Key figures of PHARMAKES, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about PHARMAKES the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to PHARMAKES?
What happened at PHARMAKES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 91,541 (▲ 180% vs 2025). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Ieper. KBO
- Roel Kestelyn became a director. NBB
In short
From € 283,001 profit in 2023 to € 91,541 profit in 2026.
Paid € 283,139 in corporate taxes since 2023.
Best year ever: 2023, with € 283,001 profit.
Paid out € 203,914 in dividends to the owners in total.
Management
Behind PHARMAKES is Roel Kestelyn. It owns 99.9% of Apotheek Kestelyn itself.
Directors
According to the 2026 annual accounts
since 2012
Establishments
Establishment units
Physical locations of this company
Izegrimstraat 4
8900 Ieper
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Ieper
Same main activity (Detailhandel in farmaceutische producten), 13 active companies in Ieper, largest first.
€ 495,399 gross margin · 2026
€ 370,450 gross margin · 2025
€ 305,034 gross margin · 2025
€ 198,063 gross margin · 2025
€ 162,115 gross margin · 2025
€ 147,618 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- KESTELYN Roel(oprichter) 99.9%
- DECRAMER Ruth Christiane(oprichter) 0.1%
Details
- Company number
- 0845.691.926
- VAT number
- BE 0845.691.926
- Registered office
- Izegrimstraat 4, 8900 Ieper
- Names & denominations
- PHARMAKES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 May 2012
- Peppol
- Active · Active since 19 Mar 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Overige zakelijke dienstverlening, neg